NPI registry status
Active
2026 NPPES data Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician NPI 1538184791 MD
Verify on CMS → Matthew Fagan, MD
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician in Newark, Delaware.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 572 in Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
697
Medicare Part D claims · 260 beneficiaries · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician avg: 611
Generic prescribing
61%
generic claims · 39% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.4K
36 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Matthew Fagan, MD filed 697 Medicare Part D claims in 2023 as a Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician in Newark, Delaware, prescribing 61% generic.
- 697
- Part D claims, 2023
- 61%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Matthew Fagan, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
697 Top 31% higher than 69% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Matthew Fagan, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Matthew Fagan, MD?
Quality data not reportedPrimary specialty
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
Medicare Part D claims
697 14% vs specialty avg
Specialty distribution in Delaware
How Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician compares to other specialties among Delaware providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Matthew Fagan, MD appears in the CMS NPPES registry as a Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider holding MD credentials at 4375 OGLETOWN STANTON ROAD, Newark, DE, 19713, with a listed phone of (302) 623-4055. NPI 1538184791 was issued on 07/12/2006.
Medicare Part D records for calendar year 2023 show 697 prescription claims written by this provider, covering 260 Medicare beneficiaries and totaling roughly $271K in drug spend, split 39% brand-name and 61% generic by claim count.
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician is a narrow specialty nationwide, with 572 enrolled providers across 49 states and an average of 611 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1538184791 |
|---|---|
| Specialty | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/12/2006 |
Hospital and facility affiliations
Facilities where Matthew Fagan, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Christiana Care Health Services Inc
Wilmington, DE
Christiana Care Pennsylvania Inc
Chadds Ford, PA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Matthew Fagan, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.4K
Largest payer
Medtronic, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
Matthew Fagan, MD - brand share 39.0%
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician average
39% brand-name claims vs 61% generic, on 697 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
697
Total Claims
$271K
Total Drug Cost
260
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,587
- Total Day Supply
- 44,335
- Brand vs Generic
- 39% brand / 61% generic
- Brand Drug Cost
- $241K
- Generic Drug Cost
- $31K
- Antibiotic Claims
- 125
Patient Demographics
- Average Patient Age
- 73.6 years
- Avg HCC Risk Score
- 1.25
- Gender Split
- 100% female / 0% male
- Age Distribution
- <65: 30, 65-74: 112, 75-84: 91, 85+: 27
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Matthew Fagan, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Myrbetriq
Myrbetriq
191 claims
- Estradiol
Estradiol
116 claims
- Nitrofurantoin Mon… 70
Nitrofurantoin Mono-Macro
70 claims
- Oxybutynin Chlorid… 65
Oxybutynin Chloride Er
65 claims
- Furosemide 42
Furosemide
42 claims
- Solifenacin Succin… 28
Solifenacin Succinate
28 claims
- Sulfamethoxazole-T… 26
Sulfamethoxazole-Trimethoprim
26 claims
- Methenamine Hippur… 20
Methenamine Hippurate
20 claims
| Drug | Claims |
|---|---|
| Myrbetriq Mirabegron | 191 |
| Estradiol | 116 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 70 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 65 |
| Furosemide | 42 |
| Solifenacin Succinate | 28 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 26 |
| Methenamine Hippurate | 20 |
| Cephalexin | 18 |
| Gemtesa Vibegron | 18 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician in DE →
All providers in Delaware →
Compare specialties →
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Overview
How Matthew Fagan, MD fits within the Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician landscape nationally.
572
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in US
49
States with Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
611
Avg Claims per Provider
Matthew Fagan, MD's 697 claims are above the specialty average of 611.
Nearby Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in Delaware
Other clinicians with the same primary specialty enrolled in Delaware, drawn from the same CMS NPPES roster as Fagan.
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Delaware medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Delaware
Frequently Asked Questions
What is Matthew Fagan, MD's specialty? ▼
Matthew Fagan, MD specializes in Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician and practices in Newark, Delaware. Credentials: MD.
How much does Matthew Fagan, MD prescribe under Medicare Part D? ▼
In 2023, Matthew Fagan, MD wrote 697 Medicare Part D claims totaling $271K in drug costs for 260 beneficiaries.
Where is Matthew Fagan, MD located? ▼
Matthew Fagan, MD is located at 4375 OGLETOWN STANTON ROAD, Newark, DE, 19713. Phone: (302) 623-4055.
What is Matthew Fagan, MD's NPI number? ▼
Matthew Fagan, MD's National Provider Identifier (NPI) is 1538184791, issued on 07/12/2006.
Does Matthew Fagan, MD prescribe more brand-name or generic drugs? ▼
Matthew Fagan, MD's prescribing is 39% brand-name and 61% generic drugs by claim count, with $241K in brand drug costs.
How many Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers are there in the US? ▼
There are 572 Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers across 49 states in the US. The average Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider writes 611 Medicare Part D claims per year.
What drugs does Matthew Fagan, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Matthew Fagan, MD's most frequently prescribed drugs include Myrbetriq, Estradiol, Nitrofurantoin Mono-Macro. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Matthew Fagan, MD accept Medicare? ▼
Matthew Fagan, MD appears in CMS Medicare data with 697 Part D claims and 260 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Matthew Fagan, MD's credentials? ▼
Matthew Fagan, MD's NPI is 1538184791 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.